tiprankstipranks
Codiak BioSciences (NASDAQ: CDAK) Drops Following Planned Public Offering
Market News

Codiak BioSciences (NASDAQ: CDAK) Drops Following Planned Public Offering

Shares of Codiak BioSciences (NASDAQ: CDAK) dropped in pre-market trading on Tuesday as the clinical-stage biopharmaceutical company announced the pricing of 13.3 million shares and accompanying warrants to purchase at a combined public offering price of $1.50 per share, together with the warrants, for gross proceeds of around $20 million.

The warrants have an exercise price of $1.875 per share which can be exercised immediately and will expire five years from the date of issuance.

The offering is expected to close on September 15, 2022.

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles